APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Granulocytes Monoclonal Antibody

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Granulocytes Monoclonal Antibody Market Analysis and Forecast 2026-2032

Report ID 173996280222 December 2025196 pages

Choose your research edition.

Industry ResearchGranulocytes Monoclonal Antibody Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Granulocytes Monoclonal Antibody Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Granulocytes Monoclonal Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Granulocytes Monoclonal Antibody Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Granulocytes Monoclonal Antibody Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Granulocytes Monoclonal Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Granulocytes Monoclonal Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Granulocytes Monoclonal Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Granulocytes Monoclonal Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Granulocytes Monoclonal Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Granulocytes Monoclonal Antibody include Abbexa, Assay Genie, Biomatik, Boster Biological Technology, CLOUD-CLONE CORP., CUSABIO, Innovative Research, LifeSpan BioSciences, Inc and MyBiosource, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Granulocytes Monoclonal Antibody, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Granulocytes Monoclonal Antibody, also provides the sales of main regions and countries. Of the upcoming market potential for Granulocytes Monoclonal Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Granulocytes Monoclonal Antibody sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Granulocytes Monoclonal Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Granulocytes Monoclonal Antibody sales, projected growth trends, production technology, application and end-user industry.

Granulocytes Monoclonal Antibody Segment by Company

Abbexa

Assay Genie

Biomatik

Boster Biological Technology

CLOUD-CLONE CORP.

CUSABIO

Innovative Research

LifeSpan BioSciences, Inc

MyBiosource, Inc.

ZodelBiotec Ltd.

RayBiotech, Inc.

Thermo Fisher

Shanghai Korain Biotech Co., Ltd.

Wuhan Fine Biotech Co., Ltd.

Granulocytes Monoclonal Antibody Segment by Type

Recombinant

Non-recombinant

Granulocytes Monoclonal Antibody Segment by Application

Immunofluorescence

Immunoprecipitation

ELISA

Flow Cytometry

Western Blot

Other

Granulocytes Monoclonal Antibody Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granulocytes Monoclonal Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Granulocytes Monoclonal Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granulocytes Monoclonal Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Granulocytes Monoclonal Antibody in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Granulocytes Monoclonal Antibody manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Granulocytes Monoclonal Antibody sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Granulocytes Monoclonal Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Recombinant Major Manufacturers Table 3. Non-recombinant Major Manufacturers Table 4. Global Granulocytes Monoclonal Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Immunofluorescence Major Manufacturers Table 6. Immunoprecipitation Major Manufacturers Table 7. ELISA Major Manufacturers Table 8. Flow Cytometry Major Manufacturers Table 9. Western Blot Major Manufacturers Table 10. Other Major Manufacturers Table 11. Granulocytes Monoclonal Antibody Industry Trends Table 12. Granulocytes Monoclonal Antibody Industry Drivers Table 13. Granulocytes Monoclonal Antibody Industry Opportunities and Challenges Table 14. Granulocytes Monoclonal Antibody Industry Restraints Table 15. Global Granulocytes Monoclonal Antibody Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Granulocytes Monoclonal Antibody Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Granulocytes Monoclonal Antibody Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Granulocytes Monoclonal Antibody Revenue Market Share by Region (2021-2026) Table 19. Global Granulocytes Monoclonal Antibody Revenue Market Share by Region (2027-2032) Table 20. Global Granulocytes Monoclonal Antibody Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Granulocytes Monoclonal Antibody Sales by Region (2021-2026) & (k units) Table 22. Global Granulocytes Monoclonal Antibody Sales by Region (2027-2032) & (k units) Table 23. Global Granulocytes Monoclonal Antibody Sales Market Share by Region (2021-2026) Table 24. Global Granulocytes Monoclonal Antibody Sales Market Share by Region (2027-2032) Table 25. Global Granulocytes Monoclonal Antibody Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Granulocytes Monoclonal Antibody Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Granulocytes Monoclonal Antibody Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Granulocytes Monoclonal Antibody Sales Market Share by Manufacturers (2021-2026) Table 29. Global Granulocytes Monoclonal Antibody Sales Price (US$/unit) of Manufacturers (2021-2026) Table 30. Global Granulocytes Monoclonal Antibody Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Granulocytes Monoclonal Antibody Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Granulocytes Monoclonal Antibody Manufacturers, Product Type & Application Table 33. Global Granulocytes Monoclonal Antibody Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Granulocytes Monoclonal Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Granulocytes Monoclonal Antibody Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Granulocytes Monoclonal Antibody Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Granulocytes Monoclonal Antibody Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Granulocytes Monoclonal Antibody Revenue Market Share by Type (2021-2026) Table 40. Global Granulocytes Monoclonal Antibody Revenue Market Share by Type (2027-2032) Table 41. Global Granulocytes Monoclonal Antibody Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Granulocytes Monoclonal Antibody Sales by Type (2021-2026) & (k units) Table 43. Global Granulocytes Monoclonal Antibody Sales by Type (2027-2032) & (k units) Table 44. Global Granulocytes Monoclonal Antibody Sales Market Share by Type (2021-2026) Table 45. Global Granulocytes Monoclonal Antibody Sales Market Share by Type (2027-2032) Table 46. Global Granulocytes Monoclonal Antibody Price by Type (2021-2026) & (US$/unit) Table 47. Global Granulocytes Monoclonal Antibody Price by Type (2027-2032) & (US$/unit) Table 48. Global Granulocytes Monoclonal Antibody Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Granulocytes Monoclonal Antibody Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Granulocytes Monoclonal Antibody Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Granulocytes Monoclonal Antibody Revenue Market Share by Application (2021-2026) Table 52. Global Granulocytes Monoclonal Antibody Revenue Market Share by Application (2027-2032) Table 53. Global Granulocytes Monoclonal Antibody Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Granulocytes Monoclonal Antibody Sales by Application (2021-2026) & (k units) Table 55. Global Granulocytes Monoclonal Antibody Sales by Application (2027-2032) & (k units) Table 56. Global Granulocytes Monoclonal Antibody Sales Market Share by Application (2021-2026) Table 57. Global Granulocytes Monoclonal Antibody Sales Market Share by Application (2027-2032) Table 58. Global Granulocytes Monoclonal Antibody Price by Application (2021-2026) & (US$/unit) Table 59. Global Granulocytes Monoclonal Antibody Price by Application (2027-2032) & (US$/unit) Table 60. Abbexa Company Information Table 61. Abbexa Business Overview Table 62. Abbexa Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 63. Abbexa Granulocytes Monoclonal Antibody Product Portfolio Table 64. Abbexa Recent Development Table 65. Assay Genie Company Information Table 66. Assay Genie Business Overview Table 67. Assay Genie Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Assay Genie Granulocytes Monoclonal Antibody Product Portfolio Table 69. Assay Genie Recent Development Table 70. Biomatik Company Information Table 71. Biomatik Business Overview Table 72. Biomatik Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Biomatik Granulocytes Monoclonal Antibody Product Portfolio Table 74. Biomatik Recent Development Table 75. Boster Biological Technology Company Information Table 76. Boster Biological Technology Business Overview Table 77. Boster Biological Technology Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Boster Biological Technology Granulocytes Monoclonal Antibody Product Portfolio Table 79. Boster Biological Technology Recent Development Table 80. CLOUD-CLONE CORP. Company Information Table 81. CLOUD-CLONE CORP. Business Overview Table 82. CLOUD-CLONE CORP. Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. CLOUD-CLONE CORP. Granulocytes Monoclonal Antibody Product Portfolio Table 84. CLOUD-CLONE CORP. Recent Development Table 85. CUSABIO Company Information Table 86. CUSABIO Business Overview Table 87. CUSABIO Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. CUSABIO Granulocytes Monoclonal Antibody Product Portfolio Table 89. CUSABIO Recent Development Table 90. Innovative Research Company Information Table 91. Innovative Research Business Overview Table 92. Innovative Research Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Innovative Research Granulocytes Monoclonal Antibody Product Portfolio Table 94. Innovative Research Recent Development Table 95. LifeSpan BioSciences, Inc Company Information Table 96. LifeSpan BioSciences, Inc Business Overview Table 97. LifeSpan BioSciences, Inc Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. LifeSpan BioSciences, Inc Granulocytes Monoclonal Antibody Product Portfolio Table 99. LifeSpan BioSciences, Inc Recent Development Table 100. MyBiosource, Inc. Company Information Table 101. MyBiosource, Inc. Business Overview Table 102. MyBiosource, Inc. Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. MyBiosource, Inc. Granulocytes Monoclonal Antibody Product Portfolio Table 104. MyBiosource, Inc. Recent Development Table 105. ZodelBiotec Ltd. Company Information Table 106. ZodelBiotec Ltd. Business Overview Table 107. ZodelBiotec Ltd. Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. ZodelBiotec Ltd. Granulocytes Monoclonal Antibody Product Portfolio Table 109. ZodelBiotec Ltd. Recent Development Table 110. RayBiotech, Inc. Company Information Table 111. RayBiotech, Inc. Business Overview Table 112. RayBiotech, Inc. Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. RayBiotech, Inc. Granulocytes Monoclonal Antibody Product Portfolio Table 114. RayBiotech, Inc. Recent Development Table 115. Thermo Fisher Company Information Table 116. Thermo Fisher Business Overview Table 117. Thermo Fisher Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Thermo Fisher Granulocytes Monoclonal Antibody Product Portfolio Table 119. Thermo Fisher Recent Development Table 120. Shanghai Korain Biotech Co., Ltd. Company Information Table 121. Shanghai Korain Biotech Co., Ltd. Business Overview Table 122. Shanghai Korain Biotech Co., Ltd. Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Shanghai Korain Biotech Co., Ltd. Granulocytes Monoclonal Antibody Product Portfolio Table 124. Shanghai Korain Biotech Co., Ltd. Recent Development Table 125. Wuhan Fine Biotech Co., Ltd. Company Information Table 126. Wuhan Fine Biotech Co., Ltd. Business Overview Table 127. Wuhan Fine Biotech Co., Ltd. Granulocytes Monoclonal Antibody Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Wuhan Fine Biotech Co., Ltd. Granulocytes Monoclonal Antibody Product Portfolio Table 129. Wuhan Fine Biotech Co., Ltd. Recent Development Table 130. North America Granulocytes Monoclonal Antibody Revenue by Type (2021-2026) & (US$ Million) Table 131. North America Granulocytes Monoclonal Antibody Revenue by Type (2027-2032) & (US$ Million) Table 132. North America Granulocytes Monoclonal Antibody Sales by Type (2021-2026) & (k units) Table 133. North America Granulocytes Monoclonal Antibody Sales by Type (2027-2032) & (k units) Table 134. North America Granulocytes Monoclonal Antibody Sales Price by Type (2021-2026) & (US$/unit) Table 135. North America Granulocytes Monoclonal Antibody Sales Price by Type (2027-2032) & (US$/unit) Table 136. North America Granulocytes Monoclonal Antibody Revenue by Application (2021-2026) & (US$ Million) Table 137. North America Granulocytes Monoclonal Antibody Revenue by Application (2027-2032) & (US$ Million) Table 138. North America Granulocytes Monoclonal Antibody Sales by Application (2021-2026) & (k units) Table 139. North America Granulocytes Monoclonal Antibody Sales by Application (2027-2032) & (k units) Table 140. North America Granulocytes Monoclonal Antibody Sales Price by Application (2021-2026) & (US$/unit) Table 141. North America Granulocytes Monoclonal Antibody Sales Price by Application (2027-2032) & (US$/unit) Table 142. North America Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. North America Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. North America Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. North America Granulocytes Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 146. North America Granulocytes Monoclonal Antibody Sales by Country (2021-2026) & (k units) Table 147. North America Granulocytes Monoclonal Antibody Sales by Country (2027-2032) & (k units) Table 148. North America Granulocytes Monoclonal Antibody Sales Price by Country (2021-2026) & (US$/unit) Table 149. North America Granulocytes Monoclonal Antibody Sales Price by Country (2027-2032) & (US$/unit) Table 150. United States Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 151. Canada Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 152. Mexico Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 153. Europe Granulocytes Monoclonal Antibody Revenue by Type (2021-2026) & (US$ Million) Table 154. Europe Granulocytes Monoclonal Antibody Revenue by Type (2027-2032) & (US$ Million) Table 155. Europe Granulocytes Monoclonal Antibody Sales by Type (2021-2026) & (k units) Table 156. Europe Granulocytes Monoclonal Antibody Sales by Type (2027-2032) & (k units) Table 157. Europe Granulocytes Monoclonal Antibody Sales Price by Type (2021-2026) & (US$/unit) Table 158. Europe Granulocytes Monoclonal Antibody Sales Price by Type (2027-2032) & (US$/unit) Table 159. Europe Granulocytes Monoclonal Antibody Revenue by Application (2021-2026) & (US$ Million) Table 160. Europe Granulocytes Monoclonal Antibody Revenue by Application (2027-2032) & (US$ Million) Table 161. Europe Granulocytes Monoclonal Antibody Sales by Application (2021-2026) & (k units) Table 162. Europe Granulocytes Monoclonal Antibody Sales by Application (2027-2032) & (k units) Table 163. Europe Granulocytes Monoclonal Antibody Sales Price by Application (2021-2026) & (US$/unit) Table 164. Europe Granulocytes Monoclonal Antibody Sales Price by Application (2027-2032) & (US$/unit) Table 165. Europe Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Europe Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Europe Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Europe Granulocytes Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 169. Europe Granulocytes Monoclonal Antibody Sales by Country (2021-2026) & (k units) Table 170. Europe Granulocytes Monoclonal Antibody Sales by Country (2027-2032) & (k units) Table 171. Europe Granulocytes Monoclonal Antibody Sales Price by Country (2021-2026) & (US$/unit) Table 172. Europe Granulocytes Monoclonal Antibody Sales Price by Country (2027-2032) & (US$/unit) Table 173. Germany Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 174. France Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 175. U.K. Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 176. Italy Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 177. Russia Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 178. Spain Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 179. Netherlands Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 180. Switzerland Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 181. Sweden Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 182. Poland Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 183. China Granulocytes Monoclonal Antibody Revenue by Type (2021-2026) & (US$ Million) Table 184. China Granulocytes Monoclonal Antibody Revenue by Type (2027-2032) & (US$ Million) Table 185. China Granulocytes Monoclonal Antibody Sales by Type (2021-2026) & (k units) Table 186. China Granulocytes Monoclonal Antibody Sales by Type (2027-2032) & (k units) Table 187. China Granulocytes Monoclonal Antibody Sales Price by Type (2021-2026) & (US$/unit) Table 188. China Granulocytes Monoclonal Antibody Sales Price by Type (2027-2032) & (US$/unit) Table 189. China Granulocytes Monoclonal Antibody Revenue by Application (2021-2026) & (US$ Million) Table 190. China Granulocytes Monoclonal Antibody Revenue by Application (2027-2032) & (US$ Million) Table 191. China Granulocytes Monoclonal Antibody Sales by Application (2021-2026) & (k units) Table 192. China Granulocytes Monoclonal Antibody Sales by Application (2027-2032) & (k units) Table 193. China Granulocytes Monoclonal Antibody Sales Price by Application (2021-2026) & (US$/unit) Table 194. China Granulocytes Monoclonal Antibody Sales Price by Application (2027-2032) & (US$/unit) Table 195. Asia Granulocytes Monoclonal Antibody Revenue by Type (2021-2026) & (US$ Million) Table 196. Asia Granulocytes Monoclonal Antibody Revenue by Type (2027-2032) & (US$ Million) Table 197. Asia Granulocytes Monoclonal Antibody Sales by Type (2021-2026) & (k units) Table 198. Asia Granulocytes Monoclonal Antibody Sales by Type (2027-2032) & (k units) Table 199. Asia Granulocytes Monoclonal Antibody Sales Price by Type (2021-2026) & (US$/unit) Table 200. Asia Granulocytes Monoclonal Antibody Sales Price by Type (2027-2032) & (US$/unit) Table 201. Asia Granulocytes Monoclonal Antibody Revenue by Application (2021-2026) & (US$ Million) Table 202. Asia Granulocytes Monoclonal Antibody Revenue by Application (2027-2032) & (US$ Million) Table 203. Asia Granulocytes Monoclonal Antibody Sales by Application (2021-2026) & (k units) Table 204. Asia Granulocytes Monoclonal Antibody Sales by Application (2027-2032) & (k units) Table 205. Asia Granulocytes Monoclonal Antibody Sales Price by Application (2021-2026) & (US$/unit) Table 206. Asia Granulocytes Monoclonal Antibody Sales Price by Application (2027-2032) & (US$/unit) Table 207. Asia Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. Asia Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. Asia Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. Asia Granulocytes Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 211. Asia Granulocytes Monoclonal Antibody Sales by Country (2021-2026) & (k units) Table 212. Asia Granulocytes Monoclonal Antibody Sales by Country (2027-2032) & (k units) Table 213. Asia Granulocytes Monoclonal Antibody Sales Price by Country (2021-2026) & (US$/unit) Table 214. Asia Granulocytes Monoclonal Antibody Sales Price by Country (2027-2032) & (US$/unit) Table 215. Japan Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 216. South Korea Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 217. India Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 218. Australia Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 219. Taiwan Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 220. Southeast Asia Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 221. SAMEA Granulocytes Monoclonal Antibody Revenue by Type (2021-2026) & (US$ Million) Table 222. SAMEA Granulocytes Monoclonal Antibody Revenue by Type (2027-2032) & (US$ Million) Table 223. SAMEA Granulocytes Monoclonal Antibody Sales by Type (2021-2026) & (k units) Table 224. SAMEA Granulocytes Monoclonal Antibody Sales by Type (2027-2032) & (k units) Table 225. SAMEA Granulocytes Monoclonal Antibody Sales Price by Type (2021-2026) & (US$/unit) Table 226. SAMEA Granulocytes Monoclonal Antibody Sales Price by Type (2027-2032) & (US$/unit) Table 227. SAMEA Granulocytes Monoclonal Antibody Revenue by Application (2021-2026) & (US$ Million) Table 228. SAMEA Granulocytes Monoclonal Antibody Revenue by Application (2027-2032) & (US$ Million) Table 229. SAMEA Granulocytes Monoclonal Antibody Sales by Application (2021-2026) & (k units) Table 230. SAMEA Granulocytes Monoclonal Antibody Sales by Application (2027-2032) & (k units) Table 231. SAMEA Granulocytes Monoclonal Antibody Sales Price by Application (2021-2026) & (US$/unit) Table 232. SAMEA Granulocytes Monoclonal Antibody Sales Price by Application (2027-2032) & (US$/unit) Table 233. SAMEA Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 234. SAMEA Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 235. SAMEA Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 236. SAMEA Granulocytes Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 237. SAMEA Granulocytes Monoclonal Antibody Sales by Country (2021-2026) & (k units) Table 238. SAMEA Granulocytes Monoclonal Antibody Sales by Country (2027-2032) & (k units) Table 239. SAMEA Granulocytes Monoclonal Antibody Sales Price by Country (2021-2026) & (US$/unit) Table 240. SAMEA Granulocytes Monoclonal Antibody Sales Price by Country (2027-2032) & (US$/unit) Table 241. Brazil Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 242. Argentina Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 243. Chile Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 244. Colombia Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 245. Peru Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 246. Saudi Arabia Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 247. Israel Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 248. UAE Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 249. Turkey Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 250. Iran Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 251. Egypt Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 252. Key Raw Materials Table 253. Raw Materials Key Suppliers Table 254. Granulocytes Monoclonal Antibody Distributors List Table 255. Granulocytes Monoclonal Antibody Customers List Table 256. Research Programs/Design for This Report Table 257. Authors List of This Report Table 258. Secondary Sources Table 259. Primary Sources List of Figures Figure 1. Granulocytes Monoclonal Antibody Image Figure 2. Global Granulocytes Monoclonal Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Granulocytes Monoclonal Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 4. Recombinant Image Figure 5. Non-recombinant Image Figure 6. Global Granulocytes Monoclonal Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Granulocytes Monoclonal Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 8. Immunofluorescence Image Figure 9. Immunoprecipitation Image Figure 10. ELISA Image Figure 11. Flow Cytometry Image Figure 12. Western Blot Image Figure 13. Other Image Figure 14. Global Granulocytes Monoclonal Antibody Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Granulocytes Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Figure 16. Global Granulocytes Monoclonal Antibody Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Granulocytes Monoclonal Antibody Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Granulocytes Monoclonal Antibody Revenue Market Share by Region (2021-2032) Figure 19. Global Granulocytes Monoclonal Antibody Sales (2021-2032) & (k units) Figure 20. Global Granulocytes Monoclonal Antibody Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Granulocytes Monoclonal Antibody Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Granulocytes Monoclonal Antibody Sales YoY (2021-2032) & (k units) Figure 23. Europe Granulocytes Monoclonal Antibody Sales YoY (2021-2032) & (k units) Figure 24. China Granulocytes Monoclonal Antibody Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Granulocytes Monoclonal Antibody Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Granulocytes Monoclonal Antibody Sales YoY (2021-2032) & (k units) Figure 27. Global Granulocytes Monoclonal Antibody Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Granulocytes Monoclonal Antibody Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Granulocytes Monoclonal Antibody Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Granulocytes Monoclonal Antibody Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Granulocytes Monoclonal Antibody Revenue Market Share by Type (2021-2032) Figure 33. Global Granulocytes Monoclonal Antibody Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Granulocytes Monoclonal Antibody Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Granulocytes Monoclonal Antibody Sales Market Share by Type (2021-2032) Figure 36. Global Granulocytes Monoclonal Antibody Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Granulocytes Monoclonal Antibody Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Granulocytes Monoclonal Antibody Revenue Market Share by Application (2021-2032) Figure 39. Global Granulocytes Monoclonal Antibody Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Granulocytes Monoclonal Antibody Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Granulocytes Monoclonal Antibody Sales Market Share by Application (2021-2032) Figure 42. North America Granulocytes Monoclonal Antibody Revenue Share by Type (2021-2032) Figure 43. North America Granulocytes Monoclonal Antibody Sales Share by Type (2021-2032) Figure 44. North America Granulocytes Monoclonal Antibody Revenue Share by Application (2021-2032) Figure 45. North America Granulocytes Monoclonal Antibody Sales Share by Application (2021-2032) Figure 46. North America Granulocytes Monoclonal Antibody Revenue Share by Country (2021-2032) Figure 47. North America Granulocytes Monoclonal Antibody Sales Share by Country (2021-2032) Figure 48. Europe Granulocytes Monoclonal Antibody Revenue Share by Type (2021-2032) Figure 49. Europe Granulocytes Monoclonal Antibody Sales Share by Type (2021-2032) Figure 50. Europe Granulocytes Monoclonal Antibody Revenue Share by Application (2021-2032) Figure 51. Europe Granulocytes Monoclonal Antibody Sales Share by Application (2021-2032) Figure 52. Europe Granulocytes Monoclonal Antibody Revenue Share by Country (2021-2032) Figure 53. Europe Granulocytes Monoclonal Antibody Sales Share by Country (2021-2032) Figure 54. China Granulocytes Monoclonal Antibody Revenue Share by Type (2021-2032) Figure 55. China Granulocytes Monoclonal Antibody Sales Share by Type (2021-2032) Figure 56. China Granulocytes Monoclonal Antibody Revenue Share by Application (2021-2032) Figure 57. China Granulocytes Monoclonal Antibody Sales Share by Application (2021-2032) Figure 58. Asia Granulocytes Monoclonal Antibody Revenue Share by Type (2021-2032) Figure 59. Asia Granulocytes Monoclonal Antibody Sales Share by Type (2021-2032) Figure 60. Asia Granulocytes Monoclonal Antibody Revenue Share by Application (2021-2032) Figure 61. Asia Granulocytes Monoclonal Antibody Sales Share by Application (2021-2032) Figure 62. Asia Granulocytes Monoclonal Antibody Revenue Share by Country (2021-2032) Figure 63. Asia Granulocytes Monoclonal Antibody Sales Share by Country (2021-2032) Figure 64. SAMEA Granulocytes Monoclonal Antibody Revenue Share by Type (2021-2032) Figure 65. SAMEA Granulocytes Monoclonal Antibody Sales Share by Type (2021-2032) Figure 66. SAMEA Granulocytes Monoclonal Antibody Revenue Share by Application (2021-2032) Figure 67. SAMEA Granulocytes Monoclonal Antibody Sales Share by Application (2021-2032) Figure 68. SAMEA Granulocytes Monoclonal Antibody Revenue Share by Country (2021-2032) Figure 69. SAMEA Granulocytes Monoclonal Antibody Sales Share by Country (2021-2032) Figure 70. Granulocytes Monoclonal Antibody Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Granulocytes Monoclonal Antibody Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant
  • Non-recombinant
Applications
  • Immunofluorescence
  • Immunoprecipitation
  • ELISA
  • Flow Cytometry
  • Western Blot
  • Other
Companies covered
  • Abbexa
  • Assay Genie
  • Biomatik
  • Boster Biological Technology
  • CLOUD-CLONE CORP.
  • CUSABIO
  • Innovative Research
  • LifeSpan BioSciences, Inc
  • MyBiosource, Inc.
  • ZodelBiotec Ltd.
  • RayBiotech, Inc.
  • Thermo Fisher
  • Shanghai Korain Biotech Co., Ltd.
  • Wuhan Fine Biotech Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Granulocytes Monoclonal Antibody Market by Type
  3. 1.2.1 Global Granulocytes Monoclonal Antibody Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Recombinant
  5. 1.2.3 Non-recombinant
  6. 1.3 Granulocytes Monoclonal Antibody Market by Application
  7. 1.3.1 Global Granulocytes Monoclonal Antibody Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Immunofluorescence
  9. 1.3.3 Immunoprecipitation
  10. 1.3.4 ELISA
  11. 1.3.5 Flow Cytometry
  12. 1.3.6 Western Blot
  13. 1.3.7 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Granulocytes Monoclonal Antibody Market Dynamics
  1. 2.1 Granulocytes Monoclonal Antibody Industry Trends
  2. 2.2 Granulocytes Monoclonal Antibody Industry Drivers
  3. 2.3 Granulocytes Monoclonal Antibody Industry Opportunities and Challenges
  4. 2.4 Granulocytes Monoclonal Antibody Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Granulocytes Monoclonal Antibody Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Granulocytes Monoclonal Antibody Revenue by Region
  3. 3.2.1 Global Granulocytes Monoclonal Antibody Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Granulocytes Monoclonal Antibody Revenue by Region (2021-2026)
  5. 3.2.3 Global Granulocytes Monoclonal Antibody Revenue by Region (2027-2032)
  6. 3.2.4 Global Granulocytes Monoclonal Antibody Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Granulocytes Monoclonal Antibody Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Granulocytes Monoclonal Antibody Sales by Region
  9. 3.4.1 Global Granulocytes Monoclonal Antibody Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Granulocytes Monoclonal Antibody Sales by Region (2021-2026)
  11. 3.4.3 Global Granulocytes Monoclonal Antibody Sales by Region (2027-2032)
  12. 3.4.4 Global Granulocytes Monoclonal Antibody Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Granulocytes Monoclonal Antibody Revenue by Manufacturers
  2. 4.1.1 Global Granulocytes Monoclonal Antibody Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Granulocytes Monoclonal Antibody Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Granulocytes Monoclonal Antibody Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Granulocytes Monoclonal Antibody Sales by Manufacturers
  6. 4.2.1 Global Granulocytes Monoclonal Antibody Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Granulocytes Monoclonal Antibody Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Granulocytes Monoclonal Antibody Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Granulocytes Monoclonal Antibody Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Granulocytes Monoclonal Antibody Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Granulocytes Monoclonal Antibody Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Granulocytes Monoclonal Antibody Manufacturers, Product Type & Application
  13. 4.7 Global Granulocytes Monoclonal Antibody Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Granulocytes Monoclonal Antibody Market CR5 and HHI
  16. 4.8.2 2025 Granulocytes Monoclonal Antibody Tier 1, Tier 2, and Tier 3
5 Granulocytes Monoclonal Antibody Market by Type
  1. 5.1 Global Granulocytes Monoclonal Antibody Revenue by Type
  2. 5.1.1 Global Granulocytes Monoclonal Antibody Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Granulocytes Monoclonal Antibody Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Granulocytes Monoclonal Antibody Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Granulocytes Monoclonal Antibody Sales by Type
  6. 5.2.1 Global Granulocytes Monoclonal Antibody Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Granulocytes Monoclonal Antibody Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Granulocytes Monoclonal Antibody Sales Market Share by Type (2021-2032)
  9. 5.3 Global Granulocytes Monoclonal Antibody Price by Type
6 Granulocytes Monoclonal Antibody Market by Application
  1. 6.1 Global Granulocytes Monoclonal Antibody Revenue by Application
  2. 6.1.1 Global Granulocytes Monoclonal Antibody Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Granulocytes Monoclonal Antibody Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Granulocytes Monoclonal Antibody Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Granulocytes Monoclonal Antibody Sales by Application
  6. 6.2.1 Global Granulocytes Monoclonal Antibody Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Granulocytes Monoclonal Antibody Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Granulocytes Monoclonal Antibody Sales Market Share by Application (2021-2032)
  9. 6.3 Global Granulocytes Monoclonal Antibody Price by Application
7 Company Profiles
  1. 7.1 Abbexa
  2. 7.1.1 Abbexa Company Information
  3. 7.1.2 Abbexa Business Overview
  4. 7.1.3 Abbexa Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbexa Granulocytes Monoclonal Antibody Product Portfolio
  6. 7.1.5 Abbexa Recent Developments
  7. 7.2 Assay Genie
  8. 7.2.1 Assay Genie Company Information
  9. 7.2.2 Assay Genie Business Overview
  10. 7.2.3 Assay Genie Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Assay Genie Granulocytes Monoclonal Antibody Product Portfolio
  12. 7.2.5 Assay Genie Recent Developments
  13. 7.3 Biomatik
  14. 7.3.1 Biomatik Company Information
  15. 7.3.2 Biomatik Business Overview
  16. 7.3.3 Biomatik Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Biomatik Granulocytes Monoclonal Antibody Product Portfolio
  18. 7.3.5 Biomatik Recent Developments
  19. 7.4 Boster Biological Technology
  20. 7.4.1 Boster Biological Technology Company Information
  21. 7.4.2 Boster Biological Technology Business Overview
  22. 7.4.3 Boster Biological Technology Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Boster Biological Technology Granulocytes Monoclonal Antibody Product Portfolio
  24. 7.4.5 Boster Biological Technology Recent Developments
  25. 7.5 CLOUD-CLONE CORP.
  26. 7.5.1 CLOUD-CLONE CORP. Company Information
  27. 7.5.2 CLOUD-CLONE CORP. Business Overview
  28. 7.5.3 CLOUD-CLONE CORP. Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CLOUD-CLONE CORP. Granulocytes Monoclonal Antibody Product Portfolio
  30. 7.5.5 CLOUD-CLONE CORP. Recent Developments
  31. 7.6 CUSABIO
  32. 7.6.1 CUSABIO Company Information
  33. 7.6.2 CUSABIO Business Overview
  34. 7.6.3 CUSABIO Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 CUSABIO Granulocytes Monoclonal Antibody Product Portfolio
  36. 7.6.5 CUSABIO Recent Developments
  37. 7.7 Innovative Research
  38. 7.7.1 Innovative Research Company Information
  39. 7.7.2 Innovative Research Business Overview
  40. 7.7.3 Innovative Research Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Innovative Research Granulocytes Monoclonal Antibody Product Portfolio
  42. 7.7.5 Innovative Research Recent Developments
  43. 7.8 LifeSpan BioSciences, Inc
  44. 7.8.1 LifeSpan BioSciences, Inc Company Information
  45. 7.8.2 LifeSpan BioSciences, Inc Business Overview
  46. 7.8.3 LifeSpan BioSciences, Inc Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 LifeSpan BioSciences, Inc Granulocytes Monoclonal Antibody Product Portfolio
  48. 7.8.5 LifeSpan BioSciences, Inc Recent Developments
  49. 7.9 MyBiosource, Inc.
  50. 7.9.1 MyBiosource, Inc. Company Information
  51. 7.9.2 MyBiosource, Inc. Business Overview
  52. 7.9.3 MyBiosource, Inc. Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 MyBiosource, Inc. Granulocytes Monoclonal Antibody Product Portfolio
  54. 7.9.5 MyBiosource, Inc. Recent Developments
  55. 7.10 ZodelBiotec Ltd.
  56. 7.10.1 ZodelBiotec Ltd. Company Information
  57. 7.10.2 ZodelBiotec Ltd. Business Overview
  58. 7.10.3 ZodelBiotec Ltd. Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 ZodelBiotec Ltd. Granulocytes Monoclonal Antibody Product Portfolio
  60. 7.10.5 ZodelBiotec Ltd. Recent Developments
  61. 7.11 RayBiotech, Inc.
  62. 7.11.1 RayBiotech, Inc. Company Information
  63. 7.11.2 RayBiotech, Inc. Business Overview
  64. 7.11.3 RayBiotech, Inc. Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 RayBiotech, Inc. Granulocytes Monoclonal Antibody Product Portfolio
  66. 7.11.5 RayBiotech, Inc. Recent Developments
  67. 7.12 Thermo Fisher
  68. 7.12.1 Thermo Fisher Company Information
  69. 7.12.2 Thermo Fisher Business Overview
  70. 7.12.3 Thermo Fisher Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Thermo Fisher Granulocytes Monoclonal Antibody Product Portfolio
  72. 7.12.5 Thermo Fisher Recent Developments
  73. 7.13 Shanghai Korain Biotech Co., Ltd.
  74. 7.13.1 Shanghai Korain Biotech Co., Ltd. Company Information
  75. 7.13.2 Shanghai Korain Biotech Co., Ltd. Business Overview
  76. 7.13.3 Shanghai Korain Biotech Co., Ltd. Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Shanghai Korain Biotech Co., Ltd. Granulocytes Monoclonal Antibody Product Portfolio
  78. 7.13.5 Shanghai Korain Biotech Co., Ltd. Recent Developments
  79. 7.14 Wuhan Fine Biotech Co., Ltd.
  80. 7.14.1 Wuhan Fine Biotech Co., Ltd. Company Information
  81. 7.14.2 Wuhan Fine Biotech Co., Ltd. Business Overview
  82. 7.14.3 Wuhan Fine Biotech Co., Ltd. Granulocytes Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Wuhan Fine Biotech Co., Ltd. Granulocytes Monoclonal Antibody Product Portfolio
  84. 7.14.5 Wuhan Fine Biotech Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Granulocytes Monoclonal Antibody Market Size by Type
  2. 8.1.1 North America Granulocytes Monoclonal Antibody Revenue by Type (2021-2032)
  3. 8.1.2 North America Granulocytes Monoclonal Antibody Sales by Type (2021-2032)
  4. 8.1.3 North America Granulocytes Monoclonal Antibody Price by Type (2021-2032)
  5. 8.2 North America Granulocytes Monoclonal Antibody Market Size by Application
  6. 8.2.1 North America Granulocytes Monoclonal Antibody Revenue by Application (2021-2032)
  7. 8.2.2 North America Granulocytes Monoclonal Antibody Sales by Application (2021-2032)
  8. 8.2.3 North America Granulocytes Monoclonal Antibody Price by Application (2021-2032)
  9. 8.3 North America Granulocytes Monoclonal Antibody Market Size by Country
  10. 8.3.1 North America Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Granulocytes Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Granulocytes Monoclonal Antibody Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Granulocytes Monoclonal Antibody Market Size by Type
  2. 9.1.1 Europe Granulocytes Monoclonal Antibody Revenue by Type (2021-2032)
  3. 9.1.2 Europe Granulocytes Monoclonal Antibody Sales by Type (2021-2032)
  4. 9.1.3 Europe Granulocytes Monoclonal Antibody Price by Type (2021-2032)
  5. 9.2 Europe Granulocytes Monoclonal Antibody Market Size by Application
  6. 9.2.1 Europe Granulocytes Monoclonal Antibody Revenue by Application (2021-2032)
  7. 9.2.2 Europe Granulocytes Monoclonal Antibody Sales by Application (2021-2032)
  8. 9.2.3 Europe Granulocytes Monoclonal Antibody Price by Application (2021-2032)
  9. 9.3 Europe Granulocytes Monoclonal Antibody Market Size by Country
  10. 9.3.1 Europe Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Granulocytes Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Granulocytes Monoclonal Antibody Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Granulocytes Monoclonal Antibody Market Size by Type
  2. 10.1.1 China Granulocytes Monoclonal Antibody Revenue by Type (2021-2032)
  3. 10.1.2 China Granulocytes Monoclonal Antibody Sales by Type (2021-2032)
  4. 10.1.3 China Granulocytes Monoclonal Antibody Price by Type (2021-2032)
  5. 10.2 China Granulocytes Monoclonal Antibody Market Size by Application
  6. 10.2.1 China Granulocytes Monoclonal Antibody Revenue by Application (2021-2032)
  7. 10.2.2 China Granulocytes Monoclonal Antibody Sales by Application (2021-2032)
  8. 10.2.3 China Granulocytes Monoclonal Antibody Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Granulocytes Monoclonal Antibody Market Size by Type
  2. 11.1.1 Asia Granulocytes Monoclonal Antibody Revenue by Type (2021-2032)
  3. 11.1.2 Asia Granulocytes Monoclonal Antibody Sales by Type (2021-2032)
  4. 11.1.3 Asia Granulocytes Monoclonal Antibody Price by Type (2021-2032)
  5. 11.2 Asia Granulocytes Monoclonal Antibody Market Size by Application
  6. 11.2.1 Asia Granulocytes Monoclonal Antibody Revenue by Application (2021-2032)
  7. 11.2.2 Asia Granulocytes Monoclonal Antibody Sales by Application (2021-2032)
  8. 11.2.3 Asia Granulocytes Monoclonal Antibody Price by Application (2021-2032)
  9. 11.3 Asia Granulocytes Monoclonal Antibody Market Size by Country
  10. 11.3.1 Asia Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Granulocytes Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Granulocytes Monoclonal Antibody Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Granulocytes Monoclonal Antibody Market Size by Type
  2. 12.1.1 SAMEA Granulocytes Monoclonal Antibody Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Granulocytes Monoclonal Antibody Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Granulocytes Monoclonal Antibody Price by Type (2021-2032)
  5. 12.2 SAMEA Granulocytes Monoclonal Antibody Market Size by Application
  6. 12.2.1 SAMEA Granulocytes Monoclonal Antibody Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Granulocytes Monoclonal Antibody Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Granulocytes Monoclonal Antibody Price by Application (2021-2032)
  9. 12.3 SAMEA Granulocytes Monoclonal Antibody Market Size by Country
  10. 12.3.1 SAMEA Granulocytes Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Granulocytes Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Granulocytes Monoclonal Antibody Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Granulocytes Monoclonal Antibody Value Chain Analysis
  2. 13.1.1 Granulocytes Monoclonal Antibody Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Granulocytes Monoclonal Antibody Production Mode & Process
  6. 13.2 Granulocytes Monoclonal Antibody Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Granulocytes Monoclonal Antibody Distributors
  9. 13.2.3 Granulocytes Monoclonal Antibody Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst